APSR2026-854

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-066
P121
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1218112-46904-APSR-854_440243.pdf
Format: PDF Only
06. Tuberculosis
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Aidil Ario Darmawan * Universitas Airlangga Department of Pulmonology and Respiratory Medicine/Faculty of Medicine Surabaya Indonesia Dr. Soetomo General Academic Hospital Department of Pulmonology and Respiratory Medicine Surabaya Indonesia
Tutik Kusmiati - Universitas Airlangga Department of Pulmonology and Respiratory Medicine/Faculty of Medicine Surabaya Indonesia Dr. Soetomo General Academic Hospital Department of Pulmonology and Respiratory Medicine Surabaya Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Aidil Ario
Darmawan
ariodarmawanpulmoua@gmail.com
+62817302463
31-40
Indonesia
Case Report
Multidrug-resistant tuberculosis lymphadenitis in a thalassemia patient: A case report
Maximum 25 words
Abstract Content
 
 
 
 
Multidrug-resistant tuberculosis (MDR-TB) lymphadenitis is a rare clinical manifestation. Patients with thalassemia possess an increased risk of tuberculosis (TB) infection due to alterations in the antioxidant glutathione pathway. This report describes a rare and complex case of MDR-TB lymphadenitis in a patient with transfusion-dependent thalassemia.
A 24-year-old female presented with an enlarging right neck mass for 11 months, accompanied by a prolonged cough, dyspnea, night sweats, and weight loss for 5 months. She was diagnosed with beta-thalassemia major at age six and required monthly leukoreduced packed red blood cell transfusions due to severe allergic reactions to standard packed red cells. She had a history of TB lymphadenitis but defaulted on treatment. Physical examination revealed a 2-centimeter solid, mobile right cervical mass and hepatosplenomegaly. Laboratory findings indicated microcytic hypochromic anemia, transaminitis, hypoalbuminemia, and hyperbilirubinemia. A fine-needle aspiration biopsy with a rapid molecular test detected Mycobacterium tuberculosis with rifampicin resistance. She was treated with an individualized long-term MDR-TB regimen comprising bedaquiline, levofloxacin, cycloserine, ethambutol, and delamanid. Linezolid was intentionally excluded from the regimen to prevent exacerbating her severe anemia. The patient successfully completed the 18-month treatment course and was declared cured, alongside continuing her regular blood transfusions.
The novelty of this case lies in the successful management of MDR-TB without the use of Linezolid, a core component of modern WHO-recommended regimens, which was contraindicated due to the patient's severe thalassemia. This case highlights the critical importance of tailoring drug-resistant TB therapy to accommodate pre-existing hematologic comorbidities. It demonstrates that with careful drug selection and multidisciplinary monitoring, favorable outcomes can be achieved in high-risk patients.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Tuberculosis, lymphadenitis, thalassemia
maximum 3 keywords and no abbreviations, separated by commas
The authors would like to acknowledge the Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, and Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, for their support in the clinical evaluation and management of the patient described in this report. The authors declare that there are no conflicts of interest related to this work. This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Written informed consent was obtained from the patient for the publication of this case report and any accompanying clinical information. All procedures performed were in accordance with institutional and ethical standards.
262